| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,960 |
6,737 |
$5.27M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,592 |
2,061 |
$3.18M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,398 |
6,287 |
$3.08M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
717 |
683 |
$2.41M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,682 |
6,791 |
$1.92M |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,694 |
2,055 |
$1.53M |
| G0378 |
Hospital observation service, per hour |
1,391 |
1,130 |
$1.19M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,625 |
3,686 |
$950K |
| 80053 |
Comprehensive metabolic panel |
17,411 |
13,988 |
$811K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,782 |
3,729 |
$776K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,510 |
3,859 |
$732K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,250 |
3,188 |
$719K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,628 |
16,104 |
$537K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,300 |
4,906 |
$429K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,887 |
4,833 |
$429K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
561 |
452 |
$414K |
| 71046 |
Radiologic examination, chest; 2 views |
3,193 |
2,561 |
$371K |
| 84484 |
|
5,895 |
3,399 |
$370K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,167 |
3,910 |
$319K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
425 |
314 |
$298K |
| 71045 |
Radiologic examination, chest; single view |
4,650 |
3,211 |
$294K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,316 |
1,883 |
$283K |
| 87631 |
|
1,915 |
1,769 |
$278K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,209 |
2,699 |
$266K |
| J2704 |
Injection, propofol, 10 mg |
3,408 |
3,170 |
$263K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,467 |
924 |
$260K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,797 |
1,654 |
$230K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,943 |
6,161 |
$214K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
14,569 |
9,011 |
$208K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,930 |
1,787 |
$180K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,049 |
964 |
$175K |
| 83605 |
|
3,406 |
2,812 |
$163K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,567 |
1,004 |
$159K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
60 |
59 |
$156K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
204 |
151 |
$154K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,988 |
4,053 |
$154K |
| 84703 |
|
3,490 |
3,068 |
$153K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,796 |
1,652 |
$150K |
| 83735 |
|
5,443 |
4,157 |
$150K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,306 |
4,528 |
$142K |
| 83880 |
|
1,502 |
1,250 |
$141K |
| 81001 |
|
7,673 |
6,617 |
$140K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,447 |
1,298 |
$136K |
| 86850 |
|
1,246 |
1,127 |
$131K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,818 |
2,436 |
$131K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
677 |
651 |
$128K |
| 83690 |
|
4,105 |
3,457 |
$128K |
| 80061 |
Lipid panel |
3,090 |
2,953 |
$121K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
362 |
329 |
$115K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,704 |
1,481 |
$111K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
703 |
658 |
$108K |
| 73562 |
|
709 |
562 |
$105K |
| 96376 |
|
2,034 |
1,353 |
$103K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,445 |
618 |
$100K |
| 80305 |
|
2,357 |
2,079 |
$99K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
377 |
325 |
$96K |
| 36415 |
Collection of venous blood by venipuncture |
21,915 |
16,638 |
$91K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,616 |
4,407 |
$89K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,482 |
594 |
$89K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,413 |
2,138 |
$89K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,003 |
3,114 |
$82K |
| 85379 |
|
890 |
786 |
$78K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,426 |
2,734 |
$77K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
212 |
177 |
$77K |
| 97161 |
|
611 |
562 |
$70K |
| 76830 |
Ultrasound, transvaginal |
350 |
316 |
$68K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,608 |
1,108 |
$68K |
| 86140 |
|
2,698 |
2,346 |
$67K |
| 84439 |
|
1,841 |
1,693 |
$66K |
| 87081 |
|
1,731 |
1,647 |
$64K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
782 |
747 |
$62K |
| 87186 |
|
1,520 |
1,360 |
$61K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,856 |
1,256 |
$59K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
574 |
528 |
$59K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,669 |
2,345 |
$58K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
461 |
432 |
$57K |
| 73630 |
|
382 |
309 |
$55K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,521 |
4,880 |
$55K |
| 73030 |
|
526 |
361 |
$54K |
| 96367 |
|
529 |
380 |
$53K |
| 86803 |
|
1,009 |
950 |
$53K |
| 73610 |
|
389 |
296 |
$51K |
| 87040 |
|
985 |
841 |
$47K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,930 |
3,541 |
$47K |
| 85610 |
|
2,712 |
2,285 |
$38K |
| 85027 |
|
1,712 |
1,470 |
$37K |
| 86901 |
|
1,403 |
1,266 |
$36K |
| 86900 |
|
1,391 |
1,258 |
$36K |
| 85730 |
|
1,250 |
1,095 |
$31K |
| 85652 |
|
2,178 |
1,936 |
$30K |
| 97162 |
|
226 |
213 |
$29K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
796 |
741 |
$28K |
| 82728 |
|
761 |
698 |
$27K |
| 73130 |
|
176 |
148 |
$26K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
535 |
405 |
$24K |
| 82570 |
|
900 |
854 |
$23K |
| 87430 |
|
677 |
648 |
$22K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,536 |
1,415 |
$21K |
| 82043 |
|
385 |
373 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,022 |
3,025 |
$18K |
| 82607 |
|
264 |
250 |
$18K |
| 83550 |
|
446 |
408 |
$17K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
584 |
454 |
$17K |
| 83540 |
|
495 |
451 |
$15K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
12 |
$14K |
| 86780 |
|
236 |
222 |
$12K |
| 81003 |
|
821 |
759 |
$12K |
| 82803 |
|
292 |
247 |
$12K |
| J2060 |
Injection, lorazepam, 2 mg |
403 |
328 |
$11K |
| 73110 |
|
64 |
54 |
$11K |
| 71250 |
|
17 |
12 |
$11K |
| 73502 |
|
83 |
63 |
$10K |
| 87205 |
|
436 |
376 |
$10K |
| 87070 |
|
217 |
191 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
30 |
30 |
$9K |
| 96368 |
|
113 |
101 |
$9K |
| 72100 |
|
58 |
51 |
$9K |
| 87147 |
|
247 |
220 |
$9K |
| 87077 |
|
216 |
193 |
$8K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
15 |
13 |
$8K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
297 |
282 |
$7K |
| 86696 |
|
80 |
75 |
$7K |
| 80306 |
|
453 |
415 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
17 |
16 |
$6K |
| 94060 |
|
16 |
12 |
$6K |
| 82746 |
|
116 |
110 |
$6K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
13 |
$5K |
| 87340 |
|
149 |
140 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
54 |
53 |
$5K |
| 84702 |
|
49 |
38 |
$4K |
| 86695 |
|
67 |
63 |
$4K |
| 81025 |
|
115 |
106 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
13 |
13 |
$4K |
| 90715 |
|
102 |
91 |
$4K |
| 84100 |
|
156 |
148 |
$4K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
118 |
105 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
100 |
93 |
$3K |
| 82550 |
|
121 |
109 |
$3K |
| 82150 |
|
74 |
65 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
129 |
94 |
$3K |
| 87808 |
|
61 |
56 |
$3K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
31 |
28 |
$2K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
41 |
29 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
20 |
12 |
$2K |
| 87210 |
|
80 |
73 |
$2K |
| 84460 |
|
116 |
100 |
$2K |
| 84450 |
|
115 |
99 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
382 |
326 |
$2K |
| 94729 |
|
16 |
12 |
$2K |
| 85007 |
|
99 |
85 |
$2K |
| 71271 |
|
12 |
12 |
$1K |
| 99215 |
Prolong outpt/office vis |
148 |
109 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
50 |
41 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
98 |
38 |
$1K |
| J1790 |
Injection, droperidol, up to 5 mg |
53 |
45 |
$1K |
| 97116 |
|
22 |
12 |
$1K |
| 80076 |
|
45 |
42 |
$998.33 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
207 |
189 |
$953.63 |
| 20610 |
|
45 |
13 |
$835.37 |
| 86038 |
|
19 |
17 |
$808.94 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
665 |
588 |
$786.97 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
33 |
27 |
$745.09 |
| 99442 |
|
90 |
59 |
$733.37 |
| 84550 |
|
32 |
27 |
$621.56 |
| 82553 |
|
13 |
12 |
$596.76 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$559.25 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
165 |
148 |
$545.54 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
17 |
14 |
$533.30 |
| J1644 |
Injection, heparin sodium, per 1000 units |
20 |
12 |
$469.39 |
| 87581 |
|
13 |
13 |
$430.21 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
17 |
12 |
$397.11 |
| 86431 |
|
15 |
13 |
$389.25 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
189 |
145 |
$371.84 |
| 82272 |
|
42 |
39 |
$344.23 |
| 82950 |
|
12 |
12 |
$260.60 |
| 90686 |
|
84 |
83 |
$128.04 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
90 |
57 |
$76.45 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
34 |
26 |
$76.41 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
67 |
60 |
$72.61 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$68.94 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
20 |
17 |
$52.65 |
| 93793 |
|
29 |
12 |
$33.82 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
40 |
25 |
$23.27 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
16 |
13 |
$0.01 |
| A9270 |
Non-covered item or service |
3,803 |
2,210 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
194 |
190 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
13 |
12 |
$0.00 |
| 80346 |
|
186 |
152 |
$0.00 |